Comparative Value of Cholinesterase Inhibitors and Memantine in Persons With Moderate-To-Severe Alzheimer’s Disease in the United States: A Cost-Effectiveness Analysis
Faculty Publications
Part of the Pharmacy and Pharmaceutical Sciences Commons
Skip to main content
